Search research articles
Contact Us
Filters
Showing results (191-200 of 355) with videos related to
Page
of 36
Sort By:
Journal for Immunotherapy of Cancer
|
March 13, 2025
Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager
Paris Kosti, Johan Abram-Saliba, Laetitia Pericou-Troquier, et al.
Cancer Research
|
June 18, 2003
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer
Lin Zhang, Nuo Yang, Jin-Wan Park, et al.
Journal for Immunotherapy of Cancer
|
July 15, 2018
CART cells are prone to Fas- and DR5-mediated cell death
Benjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2008
Ovarian cancer early detection claims are biased
Martin McIntosh, Garnet Anderson, Charles Drescher, et al.
Frontiers in Immunology
|
October 7, 2022
Enforcing GLUT3 expression in CD8<sup>+</sup> T cells improves fitness and tumor control by promoting glucose uptake and energy storage
Elisabetta Cribioli, Greta Maria Paola Giordano Attianese, Pierpaolo Ginefra, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2018
Correction to: CART cells are prone to Fas- and DR5-mediated cell death
Benjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.
Plos One
|
December 24, 2011
Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses
Cheryl Lai-Lai Chiang, Andrea R Hagemann, Rachel Leskowitz, et al.
Journal of Molecular Biology
|
November 10, 2019
CD8 Binding of MHC-Peptide Complexes in cis or trans Regulates CD8<sup>+</sup> T-cell Responses
Yang Liu, Michel A Cuendet, Laurence Goffin, et al.
Cancer Biology & Therapy
|
April 22, 2006
Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment
Ronald J Buckanovich, Dimitra Sasaroli, Ann O'brien-Jenkins, et al.
Cancer Research
|
February 15, 2024
Editor's Note: In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
De-Gang Song, Qunrui Ye, Carmine Carpenito, et al.
Page
of 36
Search research articles
Search
Showing results (191-200 of 355) with videos related to
Sort By:
Page
of 36
Journal for Immunotherapy of Cancer
|
March 13, 2025
Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager
Paris Kosti, Johan Abram-Saliba, Laetitia Pericou-Troquier, et al.
Cancer Research
|
June 18, 2003
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer
Lin Zhang, Nuo Yang, Jin-Wan Park, et al.
Journal for Immunotherapy of Cancer
|
July 15, 2018
CART cells are prone to Fas- and DR5-mediated cell death
Benjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2008
Ovarian cancer early detection claims are biased
Martin McIntosh, Garnet Anderson, Charles Drescher, et al.
Frontiers in Immunology
|
October 7, 2022
Enforcing GLUT3 expression in CD8<sup>+</sup> T cells improves fitness and tumor control by promoting glucose uptake and energy storage
Elisabetta Cribioli, Greta Maria Paola Giordano Attianese, Pierpaolo Ginefra, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2018
Correction to: CART cells are prone to Fas- and DR5-mediated cell death
Benjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.
Plos One
|
December 24, 2011
Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses
Cheryl Lai-Lai Chiang, Andrea R Hagemann, Rachel Leskowitz, et al.
Journal of Molecular Biology
|
November 10, 2019
CD8 Binding of MHC-Peptide Complexes in cis or trans Regulates CD8<sup>+</sup> T-cell Responses
Yang Liu, Michel A Cuendet, Laurence Goffin, et al.
Cancer Biology & Therapy
|
April 22, 2006
Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment
Ronald J Buckanovich, Dimitra Sasaroli, Ann O'brien-Jenkins, et al.
Cancer Research
|
February 15, 2024
Editor's Note: In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
De-Gang Song, Qunrui Ye, Carmine Carpenito, et al.
Page
of 36